logo
Sign in

Third Pole, Inc.

San Francisco, CA · Founded 2014 · Medtech · Private

Tank-less medical device that generates medical-grade nitric oxide from air using iridium-electrode technology for inhalation therapy

Claim this profile

Follows are private to you and power your alerts

Updated · pole3.com

Sector
Medtech
Headquarters
San Francisco, CA
Founded
2014
Latest Form D
$2.2M, Mar 2024
Total capital
$26.5M
Federal grants
$10.2M
9 awards · 2016–2022
Rank in peer group#41 of 538
Private capital raised
$16.2M
3 Form D · last Mar 2024
31 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
23
17 pending · first 2019
Rank in peer group#16 of 538

Capital timeline

20152017201920212023FEDERAL ↑EQUITY ↓Cumulative $26.5M$1.1M$927K$3M$988K$980K$999K1st Form D$1.5M2nd Form D$12.5M3rd Form D$2.2M
20152017201920212023FEDERAL ↑EQUITY ↓Cumulative $26.5M$1.1M$3M$988K$999K1st Form D$1.5M2nd Form D$12.5M3rd Form D$2.2M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$2.2M
  • Federal grantHealth and Human S · Phase II · Portable electrical nitric oxide generator for treatment of pulmonary hypertension accompanying interstitial lung disease$792K
  • Federal grantHealth and Human S · Phase II · Portable electrical nitric oxide generator for treatment of pulmonary hypertension accompanying interstitial lung disease$999K
  • Federal grantHealth and Human S · Phase II · Iridium-electrode inhaled Nitric Oxide generator for treatment of hypoxic respiratory failure in neonates$980K
  • Federal grantHealth and Human S · Phase II · Iridium-electrode inhaled Nitric Oxide generator for treatment of hypoxic respiratory failure in neonates$988K
  • Federal grantHealth and Human S · Phase II · Iridium-electrode inhaled Nitric Oxide generator for treatment of hypoxic respiratory failure in neonates$3M
  • Private capital raisedForm D · SEC · 2nd filing$12.5M
  • Private capital raisedForm D · SEC · 1st filing$1.5M
Show 4 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Portable iridium-electrode inhaled Nitric Oxide generator for treatment of lung diseases$927K
  • Federal grantHealth and Human S · Phase II · Iridium-electrode inhaled Nitric Oxide generator for treatment of hypoxic respiratory failure in neonates$745K
  • Federal grantHealth and Human S · Phase II · Iridium-electrode inhaled Nitric Oxide generator for treatment of hypoxic respiratory failure in neonates$754K
  • Federal grantHealth and Human S · Phase II · Portable iridium-electrode inhaled Nitric Oxide generator for treatment of lung diseases$1.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#41 · top 8%
  • Granted patents#16 · top 3%
  • Linked publications#22 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • David ZapolResearcherExecutive Officer, Director, PromoterLinked by 1 patent
  • Ashleigh PalmerDirectorNamed in SEC Form D filings
  • Basil AthensonExecutive Officer, DirectorNamed in SEC Form D filings
  • Elizabeth HolmbergExecutive OfficerNamed in SEC Form D filings
  • Emily Ladd-KravitzExecutive OfficerNamed in SEC Form D filings
  • Hirak ParikhDirectorNamed in SEC Form D filings
Show all 13 people
  • Jeffrey McCormickDirectorNamed in SEC Form D filings
  • KADIR KADHIRESANDirectorNamed in SEC Form D filings
  • Kunal PaymasterDirectorNamed in SEC Form D filings
  • Matthew GaylordDirectorNamed in SEC Form D filings
  • Ron RobisonDirectorNamed in SEC Form D filings
  • Werner CautreelsDirectorNamed in SEC Form D filings
  • William HeidenDirectorNamed in SEC Form D filings

What it has protected

USPTO · 23 granted of 40
Show all 40 patent records

Recent research by its founders

  • Exhaled and nasal NO measurement: NO in your breath doesn’t imply a negative attitude!20215 cites
  • Bruxism Relieved Under CPAP Treatment in a Patient With OSA Syndrome202022 cites
  • The key role of the mandible in modulating airflow amplitude during sleep202015 cites

Related companies, and why

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .